—the disclosure of confidential price rebates by pharmaceutical companies, and the ability to amend the act to take into account pharmacoeconomics and market size.
On May 2nd, 2023. See this statement in context.
On May 2nd, 2023. See this statement in context.
May 2nd, 2023 / 11:35 a.m.
NDP
Don Davies NDP Vancouver Kingsway, BC
—the disclosure of confidential price rebates by pharmaceutical companies, and the ability to amend the act to take into account pharmacoeconomics and market size.
See context to find out what was said next.